Objective: Loss-of-function mutations in IGSF1 result in X-linked central congenital hypothyroidism (CeCH), occurring in isolation or associated with additional pituitary hormone deficits. Intrafamilial penetrance is highly variable and a minority of heterozygous females are also affected. We identified and characterized a novel IGSF1 mutation and investigated its associated phenotypes in a large Irish kindred.
| INTRODUC TI ON
Since the initial description of IGSF1 mutations in eleven European kindreds, larger studies have substantiated the complex nature of the IGSF1 deficiency syndrome as well as confirming the relatively frequent occurrence of IGSF1 mutations in CeCH cases. 4, 7 IGSF1 encodes a transmembrane immunoglobulin superfamily glycoprotein that undergoes co-translational proteolysis such that only its seven carboxyterminal immunoglobulin loops are expressed extracellularly at the plasma membrane. 8 The majority of previously reported IGSF1 mutations adversely affect trafficking and membrane localization of this carboxy-terminal domain 9 ( Figure 1A ). IGSF1 is abundantly detected at mRNA level in Rathke's pouch and adult pituitary gland 4 ; however, a paucity of reliable antibodies has hampered expression studies in humans. In rodents, differential antibody usage has yielded divergent results; IGSF1 protein has been detected in all cells of the Pou1f1 (Pit1) lineage in murine and rat pituitaries using one custom IGSF1-CTD antibody 4, 10 ; however, a different, commercially available anti-IGSF1
antibody (Genetex) localized IGSF1 to thyrotropes and gonadotropes in rats, but not somatotropes or lactotropes. 11 Despite clinical and murine data supporting a role for IGSF1 in regulation of TRH action in the pituitary, its molecular function remains undefined. 4, 12, 13 Hormone deficiencies associated with IGSF1 mutations may involve all cells of the POU1F1 lineage. Hemizygous males almost universally exhibit central hypothyroidism and 60% have basal hypoprolactinaemia; a minority (~15%) exhibit transient childhood growth hormone (GH) deficiency. 9 Endocrine evaluation of heterozygous females usually reveals a milder phenotype with FT4 concentrations in the lower tertile of the normal range, although 18% do exhibit overt central hypothyroidism and 22% have subnormal basal prolactin. 7, 9 Affected boys exhibit delayed pubertal testosterone rise and growth spurt, associated with preserved testicular growth and development of macroorchidism from late adolescence onwards. 4, 9 Additional features include raised BMI, and mildly elevated or highnormal adult IGF-1 concentrations. 7, 9 Biochemical and physiological severity of CeCH are variable in IGSF1 deficiency (including in congenic mouse strains), and some individuals tolerate lifelong thyroid hormone deficiency without apparent adverse consequences, whereas others present symptomatically early on. 4 
| MATERIAL S AND ME THODS
The study was approved by Cambridge South REC (MREC 98/5/24) and includes additional measurements undertaken as part of routine clinical follow-up with consent from patients and/or next of kin.
| Sanger sequencing of IGSF1
Genomic DNA was extracted from peripheral blood leukocytes using standard techniques. In the probands, all 20 IGSF1 exons and exon/intron boundaries were amplified by PCR using specific primers (available on request). Family members were genotyped for the identified missense mutation (see Results) by amplifying and sequencing exon 13 alone. PCR products were sequenced using the BigDye Terminator v3. 
| Clinical measurements
All biochemical measurements were performed in CPA (Clinical Pathology Accreditation) and INAB (Irish National Accreditation Board) accredited laboratories, using local automated assays, and results were compared to local reference ranges (age and genderspecific where appropriate). Auxological measurements were performed by trained auxologists during clinical visits, and SDS scores were computed according to published reference data [15] [16] [17] using GrowthXP Endo, a children growth monitoring commercial programme.
Relevant medical history was acquired by review of patients' notes or direct questioning. Unless otherwise stated, reference ranges refer to 95% confidence intervals, and variance is reported as standard deviation score. Sleeping heart rate was compared to a locally-generated reference range for healthy males and depicts minimum and maximum. Basal metabolic rate was measured using ventilated hood indirect calorimetry as described in. 
| TRH tests
TSH, FT4, free triiodothyronine (FT3) and prolactin were measured in serum samples taken at baseline and at 20, 60, 90, 120, 150 and 
| Testicular volume assessment
Calculation of ultrasonographic testicular volume was computed as previously described and compared with published reference data. 19 Testicular volumes in children were assessed clinically by a trained paediatric endocrinologist using the Prader Orchidometer.
| In vitro analysis of the mutant IGSF1 protein
The L773P mutation was introduced into the human myc-IGSF1-HA expression vector described in Transfections, cell surface biotinylation, immunoprecipitations, SDS-PAGE and immunoblotting were performed as described in. Tables 1 and 2; Tables S1-S3 
| Pathogenicity of mutation
The missense variant identified was absent from published databases 
| Additional genetic ascertainment and endocrine evaluation
Family screening identified an additional eight hemizygous males (five children and three adults) and eleven heterozygous females.
Baseline endocrinology and auxology was assessed, and dynamic endocrine testing was performed in a subset of individuals (Figures 2-5 ; Tables 1 and 2; Supporting Information Tables S1-S3 ).
| Thyroid function
All evaluable male cases exhibited central hypothyroidism (FT4 ranging from 6.9 to 10.2 pmol/L, mean Z-score −3.3 ± 0.4) although biochemical penetrance was variable. In all cases, FT3 concentrations were maintained within the reference range (mean Z-score −0.8 ± 0.8) despite a subnormal FT4, and in three evaluable cases, this was achieved at the expense of low/low normal reverse T3 concentrations ( Figures 2 and 4) . Assessment of physiological thyroid status is challenging due to a paucity of sensitive and specific biomarkers; however, we screened our cases for features potentially attributable to tissue hypothyroidism including high birth weight, neonatal complications of hypothyroxinaemia, obesity, developmental delay, growth impairment and symptoms such as constipation and fatigue ( Table 1) . Three of seven cases for whom data was available (3a, 3c, 3g) exhibited birth weight SDS scores of greater than +2.0 and case 1a was reportedly a "large baby" with an estimated birth weight of around 4.5 kg; cases 3d and 3e exhibited low birth weight SDS which may have been attributable to maternal renal disease. One child and two adolescents (cases 3a, 3h, and 3i) with mild-moderate central hypothyroidism, exhibited growth retardation or a decline in growth velocity; as previously detailed, 3a 13.7 ± 1.39 pmol/L, mean Z-score −0.5 ± 0.3) ( Table 2 ).
| Prolactin
Prolactin concentrations were usually in the lower half of the reference range (hemizygotes; mean Z-score −1.5 ± 1.4, heterozygotes; mean Z score −1.2 ± 1.2). One hemizygous adult and three children exhibited hypoprolactinaemia, with prolactin concentrations ranging from undetectable (case 3a) to subnormal (cases 3c, 3e, and 1c)
or low-normal [case 3d, 92 mU/L (RR 90-320)]. Two heterozygous adults and one child were hypoprolactinaemic; however, both adults experienced no problems with pregnancy although case 2b did experience difficulties with lactation with her two sons (Tables 1 and   2 ; Supporting Information Tables S1 and S2).
| Gonadal axis
The FSH:LH ratio was in the upper part of the reference range in the three male hemizygous adults, mean 2.91 (RR 0.4-3.4) ( Table 1;   Table S1 ). Ultrasonography in case 1a confirmed macro-orchidism 
| Growth hormone
Two male cases had either low normal (3i) or mildly subnormal (3h) IGF-1 concentrations at diagnosis; however, both were evaluated whilst hypothyroid and peripubertal (aged 12 and 13 years); therefore, GH deficiency could not be definitively excluded or confirmed. Case 3i showed improved growth on levothyroxine, but Case 3h was still growing slowly at age 14.5 years (height (Tables 1 and 2; Supporting Information Tables S1 and S2 ). 1a, 3d, h, i) but subnormal in Cases 3a and 3e, who had basal hypoprolactinaemia, although a fivefold increase in Case 3e confirmed some prolactin reserve ( Figure 5 ; Supporting Information Table S3 ).
| TRH testing

| D ISCUSS I ON
We identified a novel IGSF1 missense mutation in a three-generation Irish kindred. This is the largest reported family to date, with endocrine evaluation of 10 hemizygous males and 11 heterozygous females. Previously described IGSF1 mutations include four whole-gene deletions, 4, 11, 21 multiple premature truncations and missense mutations, 2 splice-site mutations and a 27-bp deletion 4, 7, 9, [22] [23] [24] [25] [26] [27] [28] ( Figure 1A ).
Affected individuals in our kindred exhibit classical endocrine manifestations of IGSF1 deficiency, and characterization of the p.L773P mutation in vitro demonstrates deficits in trafficking of the protein from the endoplasmic reticulum to the cell surface, as has been described for previously-reported pathogenic IGSF1 mutations. 4, 7, 9 In keeping with previous reports, biochemical penetrance of thy- Biochemical severity of hypothyroidism did not predict coexistence of other hormone deficiencies; however, three males exhibited subnormal/borderline basal prolactin. In keeping with previous reports, hemizygous cases (n = 4) with normal basal prolactin exhibited a normal prolactin response to TRH, whereas the peak was blunted in the context of basal hypoprolactinaemia ( Figure 5 , Cases 3a and 3e). 22, 23, 26 The role of IGSF1 in prolactin production remains unclear and is likely to involve pathways separate from the TRHR, as TRHR signalling is not required for normal basal prolactin production.
2,31
Female hypoprolactinaemia had no apparent effect on pregnancy, although one individual experienced difficulties with lactation.
Although IGSF1 expression has been reported in murine and rat somatotrophs, its role in GH dynamics may be complex. GH deficiency occurs rarely in IGSF1 deficiency; however, IGF-1 is usually in the upper part of normal range in IGSF1 deficient adults and may be associated with acromegaloid features consistent with mild GH excess. 7, 9 In our kindred, one individual had GH deficiency and another had insufficient GH concentrations on stimulation testing with normal IGF-1 and growth velocity. However, the potential for puberty to be delayed in the context of IGSF1 deficiency may complicate interpretation of these results. Two adult heterozygotes had mildly elevated IGF-1 concentrations (Cases 1d and 2a) and one hemizygote (Case 1a) exhibited acromegaloid facies with inappropriately preserved IGF-1 given his hypothyroidism. Cortisol production was not evaluated systematically in our kindred; however, transient neonatal hypocortisolism has also been reported in IGSF1 deficiency. 9 In this context, it is noteworthy that 3a exhibited neonatal hypoglycaemia; although this is a recog- 
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